UV-visible Spectrophotometric Estimation of Montelukast and Fexofenadine by Simultaneous Equation Method in Bulk & Combined Tablet dosage form

Order of Publishing in Issue: 
Volume :11
Issue :4
October, 2017 - December, 2017
Page No: 
Deepshikha Patle*[1] and Sohil Nagar[2]
[1]Faculty of Pharmaceutical Sciences, PCTE Group of Institutes, Ludhiana, Punjab, India-141004
[2]MGV’s Pharmacy College Panchavati, Nashik-422003, Maharashtra, India

A simple, rapid, accurate and precise spectrophotometric method has been developed for simultaneous estimation of Montelukast Sodium and Fexofenadine HCl in Pure and tablet dosage form. Proposed method involves formation of ‘simultaneous equations’ at 259.60nm for Fexofenadine Hydrochloride and 283.00 nm for Montelukast Sodium using methanol as a solvent. The linearity was observed in the concentration range of 30-120 mg/ml for Fexofenadine HCl and 6-20 mg/ml for Montelukast Sodium. The correlation coefficient was found to be 0.9927 for fexofenadine HCl and 0.9985 for Montelukast Sodium. Thus the proposed method is reproducible which can be suitably applied for the estimation of FEXO &MONT in combined dosage forms. The results of analysis have been validated statistically and by recovery studies.

Fexofenadine HCl (FEXO), Montelukast Sodium (MONT), Simultaneous equation method, Spectrophotometry.
PDF305.54 KB

To download full text articles and issues in PDF at no cost.All you have to do is fill out a brief registration form. It's easy and it's free. At any time, you may request removal of your contact information from our database.
Click here to Register | Click here if you have already registered

2018 ABAP Awards

Invitation for Nominations to 2019 ABAP Awards
The Association of Biotechnology and Pharmacy invites nominations for the following awards from the eligible talented people with proven track record and achievements on or before August 31, 2019 in the prescribed format.



User login